Dillard, Jacob A. http://orcid.org/0000-0002-6560-1494
Taft-Benz, Sharon A.
Knight, Audrey C.
Anderson, Elizabeth J. http://orcid.org/0000-0001-7877-1639
Pressey, Katia D.
Parotti, Breantié
Martinez, Sabian A.
Diaz, Jennifer L. http://orcid.org/0000-0002-8067-0420
Sarkar, Sanjay
Madden, Emily A.
De la Cruz, Gabriela
Adams, Lily E.
Dinnon, Kenneth H. III
Leist, Sarah R. http://orcid.org/0000-0002-4989-5381
Martinez, David R.
Schäfer, Alexandra http://orcid.org/0000-0002-4760-4923
Powers, John M. http://orcid.org/0000-0002-0485-9109
Yount, Boyd L. Jr.
Castillo, Izabella N.
Morales, Noah L.
Burdick, Jane
Evangelista, Mia Katrina D.
Ralph, Lauren M.
Pankow, Nicholas C.
Linnertz, Colton L.
Lakshmanane, Premkumar
Montgomery, Stephanie A.
Ferris, Martin T.
Baric, Ralph S. http://orcid.org/0000-0001-6827-8701
Baxter, Victoria K. http://orcid.org/0000-0003-0916-360X
Heise, Mark T. http://orcid.org/0000-0001-5829-8477
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U19 AI100625, R01 AI157253, U19 AI109680, K01 OD026529, 5T32 AI007419-30, T32 GM008719, P30CA016086, U01AI149644, U54 CA260543)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 6 October 2023
Accepted: 2 April 2024
First Online: 3 May 2024
Competing interests
: R.S.B. has served on the Scientific Advisory Boards for Takeda vaccines, VaxArt and Invivyd Therapeutics, and has collaborations with Gilead, Janssen Pharmaceuticals, Pardas Biosciences, and Chimerix. M.T.H. has collaborations with Moderna, Inc. and Chimerix. R.S.B., K.H.D. III, and S.R.L. are listed as inventors on patents pertaining to the mouse-adapted SARS-CoV-2 viruses (MA10 and MA10-B.1.351; Patent number 11,225,508) and the SARS-CoV-2 nanoLuciferase viruses (SARS-CoV-2-nLuc and B.1.351-nLuc; Patent number 11,492,379) used in this study. The remaining authors declare no competing interests.